111 related articles for article (PubMed ID: 25889408)
1. Effect of conjugated linoleic acid on blood pressure: a meta-analysis of randomized, double-blind placebo-controlled trials.
Yang J; Wang HP; Zhou LM; Zhou L; Chen T; Qin LQ
Lipids Health Dis; 2015 Feb; 14():11. PubMed ID: 25889408
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Dong JY; Qin LQ; Zhang Z; Zhao Y; Wang J; Arigoni F; Zhang W
Am Heart J; 2011 Dec; 162(6):959-65. PubMed ID: 22137067
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
4. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials.
Zhang X; Li Y; Del Gobbo LC; Rosanoff A; Wang J; Zhang W; Song Y
Hypertension; 2016 Aug; 68(2):324-33. PubMed ID: 27402922
[TBL] [Abstract][Full Text] [Related]
5. Effects of Melatonin Supplementation On Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hadi A; Ghaedi E; Moradi S; Pourmasoumi M; Ghavami A; Kafeshani M
Horm Metab Res; 2019 Mar; 51(3):157-164. PubMed ID: 30861561
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of randomized controlled trials of azilsartan therapy for blood pressure reduction.
Takagi H; Mizuno Y; Niwa M; Goto SN; Umemoto T
Hypertens Res; 2014 May; 37(5):432-7. PubMed ID: 24108238
[TBL] [Abstract][Full Text] [Related]
7. Effect of conjugated linoleic acid on blood inflammatory markers: a systematic review and meta-analysis on randomized controlled trials.
Haghighatdoost F; Nobakht M Gh BF
Eur J Clin Nutr; 2018 Aug; 72(8):1071-1082. PubMed ID: 29288248
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.
Young JM; Florkowski CM; Molyneux SL; McEwan RG; Frampton CM; Nicholls MG; Scott RS; George PM
Am J Hypertens; 2012 Feb; 25(2):261-70. PubMed ID: 22113168
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Hypertens Res; 2013 Jul; 36(7):627-33. PubMed ID: 23344134
[TBL] [Abstract][Full Text] [Related]
10. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.
Kanaki AI; Sarafidis PA; Georgianos PI; Stafylas PC; Kanavos K; Tziolas IM; Lasaridis AN
J Hum Hypertens; 2012 Oct; 26(10):577-84. PubMed ID: 21881597
[TBL] [Abstract][Full Text] [Related]
11. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
Zanchetti A; Thomopoulos C; Parati G
Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
[TBL] [Abstract][Full Text] [Related]
13. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension.
Zhao WS; Zhai JJ; Wang YH; Xie PS; Yin XJ; Li LX; Cheng KL
Am J Hypertens; 2009 Jun; 22(6):680-6. PubMed ID: 19300423
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Hypertens Res; 2013 Nov; 36(11):959-66. PubMed ID: 23945962
[TBL] [Abstract][Full Text] [Related]
16. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
18. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
19. Effect of Home Medication Titration on Blood Pressure Control in Patients With Hypertension: A Meta-Analysis of Randomized Controlled Trials.
Chen TY; Kao CW; Cheng SM; Chang YC
Med Care; 2019 Mar; 57(3):230-236. PubMed ID: 30762831
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies.
Fogacci F; Tocci G; Sahebkar A; Presta V; Banach M; Cicero AFG
Angiology; 2020 Mar; 71(3):217-225. PubMed ID: 31763928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
